These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17470962)

  • 1. Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study.
    Haessler F; Glaser T; Beneke M; Pap AF; Bodenschatz R; Reis O;
    Br J Psychiatry; 2007 May; 190():447-8. PubMed ID: 17470962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.
    Hässler F; Dück A; Jung M; Reis O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):579-81. PubMed ID: 25514543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F; Glaser T; Pap AF; Beneke M; Diefenbacher A; Reis O;
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zuclopenthixol on aggressive disruptive behavior in adults with mental retardation--a 2-year follow-up on a withdrawal study.
    Hässler F; Glaser T; Reis O
    Pharmacopsychiatry; 2011 Nov; 44(7):339-43. PubMed ID: 21993867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
    Spivak B; Mozes T; Mester R; Kodelik M; Weizman A
    J Child Adolesc Psychopharmacol; 2001; 11(3):279-84. PubMed ID: 11642477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders.
    Singh I; Owino WJ
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():541-9. PubMed ID: 1477491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
    Amore M; Bertelli M; Villani D; Tamborini S; Rossi M
    J Intellect Disabil Res; 2011 Feb; 55(2):210-8. PubMed ID: 21129058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of zuclopenthixol in the treatment of aggression in Huntington's disease.
    Tibrewal P; Bastiampillai T; Dhillon R; Cheng R; Fonseka HT
    Asian J Psychiatr; 2017 Apr; 26():152-153. PubMed ID: 28483083
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
    Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
    Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.
    Oliver-Africano P; Dickens S; Ahmed Z; Bouras N; Cooray S; Deb S; Knapp M; Hare M; Meade M; Reece B; Bhaumik S; Harley D; Piachaud J; Regan A; Ade Thomas D; Karatela S; Rao B; Dzendrowskyj T; Lenôtre L; Watson J; Tyrer P
    J Intellect Disabil Res; 2010 Jan; 54(1):17-25. PubMed ID: 19627427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
    Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K
    Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
    Nygaard HA; Fuglum E; Elgen K
    Curr Med Res Opin; 1992; 12(10):615-22. PubMed ID: 1353014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
    Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
    Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.